§ 130 c Abs. 1 SGB V Nucala (R) Mepolizumab ATC-Code: R03DX09
Tender information
DE_BKMSMünchen, Germany
- Procedure
- Negotiated without prior call for competition
- Ref. number
- 607ded52-0bae-4d67-825f-67088f7b8b16
- CPV
- 33600000
Arzneimittelrabattvertrag § 130 c Abs. 1 SGB V Arzneimittel Nucala (R), ATC-Code: R03DX09 Wirkstoff: Mepolizumab